The quarter reflected steady revenue growth but underscored challenges in profit conversion, as seen in declining operating ...
Investor's Business Daily on MSN23h
Dexcom Stock Makes A Recovery After Its Fourth-Quarter FumbleDexcom stock stock recovered Friday after the diabetes devices maker missed fourth-quarter profit expectations.
DexCom reported Q4 revenue of $1.11 billion, surpassing estimates. The company reaffirmed its 2025 outlook while analysts ...
DexCom (NASDAQ: DXCM) is a healthcare company that makes continuous glucose monitoring (CGM) devices, which help people track ...
Today, Benzinga's options scanner identified 8 options transactions for DexCom. This is an unusual occurrence. The sentiment ...
An Apple Watch, which integrates easily into the Dexcom CGM ecosystem ... Until then, if you need a primer on continuous glucose monitoring, we’re happy to oblige.
Stratos Wealth Partners LTD. purchased a new stake in DexCom, Inc. (NASDAQ:DXCM – Free Report) in the fourth quarter, HoldingsChannel.com reports. The fund purchased 2,583 shares of the medical device ...
Medical device specialist DexCom (NASDAQ: DXCM) has substantially underperformed the market over the trailing-12-month period ...
Living with Type 1 diabetes is a numbers game. There’s not a moment in the day free from the burden of tracking your blood ...
A U.K. court has ruled against Abbott in a trademark infringement case the company had brought over the design of a rival ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback